Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial-Reference-Cited by-同舟云学术

Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial

Published:2022-02 Issue:2 Volume:9 Page:e121-e132
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Copland Mhairi,Slade Daniel,McIlroy Graham,Horne Gillian,Byrne Jenny L,Rothwell Kate,Brock Kristian,De Lavallade Hugues,Craddock Charles,Clark Richard E,Smith Matthew L,Fletcher Rachel,Bishop Rebecca,Milojkovic Dragana,Yap Christina

Funder

Incyte Corp

Blood Cancer UK

Publisher

Elsevier BV

Subject

Hematology

Reference35 articles.

1. Long-term outcomes of imatinib treatment for chronic myeloid leukemia;Hochhaus;N Engl J Med,2017

2. Final 5-year study results of DASISION: the dasatinib versus imatinib study in treatment-naïve chronic myeloid leukemia patients trial;Cortes;J Clin Oncol,2016

3. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial;Hochhaus;Leukemia,2016

4. Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis;Kantarjian;Leukemia,2021

5. Management of CML-blast crisis;Hehlmann;Best Pract Res Clin Haematol,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study;Blood Cancer Journal;2024-05-31

2. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.;2024-04-09

3. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry;Leukemia;2024-03-28

4. Prognostic Factors and Clinical Outcomes in Patients with Blast Phase Chronic Myeloid Leukemia;Clinical Laboratory;2024

5. Accelerated-phase CML: de novo and transformed;Hematology;2023-12-08